Percutaneous closure of moderate to large perimembranous ventricular septal defect in small children using left

Sanjiban Ghosh1, Aritra Mukherji1, Amitabha Chattopadhyay1

  • 1Department of Pediatric Cardiology, Narayana Superspeciality Hospital, Howrah, India.

Indian Heart Journal
|December 28, 2020
PubMed

Insights

Transcatheter closure of perimembranous Ventricular Septal Defect (VSD) using the Amplatzer Duct Occlude-I device is effective in small children. The left ventricular mid-cavity approach offers advantages over standard techniques.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Perimembranous Ventricular Septal Defects (VSD) are common congenital heart abnormalities.
  • Transcatheter closure is an alternative to surgical repair for VSD.
  • Small children (<10 kg) present unique challenges for VSD closure.

Purpose of the Study:

  • To evaluate the mid-term outcomes of transcatheter closure for perimembranous VSD in infants weighing less than 10 kg.
  • To assess the efficacy and safety of the Amplatzer Duct Occlude-I (ADO-I) device using a left ventricular (LV) mid-cavity approach.
  • To compare the LV mid-cavity approach with the standard technique in terms of procedural and clinical outcomes.

Main Methods:

  • Retrospective review of 35 children (<10 kg) with moderate to large perimembranous VSD.
  • Transcatheter closure performed using ADO-I via an LV mid-cavity approach.
  • Data collected on procedural parameters, complications, and follow-up outcomes.

Main Results:

  • Successful device closure achieved in 32 out of 35 patients (91.4%).
  • One patient developed device-induced aortic regurgitation requiring surgery.
  • One patient experienced complete heart block requiring pacemaker implantation.
  • No residual VSD, rhythm disturbances, or significant hemodynamic issues were noted during follow-up.

Conclusions:

  • Transcatheter closure of moderate to large perimembranous VSD is feasible and effective in small children using the LV mid-cavity approach with ADO-I.
  • The LV mid-cavity approach demonstrates potential benefits including reduced hemodynamic instability, decreased fluoroscopy time, and a lower incidence of device-induced aortic regurgitation compared to the standard technique.
Abstract